Sodium-Glucose Cotransporter-2 Inhibitors Linked to Reduced Risk for Gout
Researchers studied the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and gout, using a cohort study design and a symmetry analysis.
Sheila Jacobs
Contributing Writer
Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.
